Longitudinal study based on a safety registry for malaria patients treated with artenimol–piperaquine in six European countries

Nicolas Vignier, Olivier Bouchaud, Andrea Angheben, Emmanuel Bottieau, Guido Calleri, Joaquín Salas-Coronas, Charlotte Martin, José Manuel Ramos, Matthieu Mechain, Christophe Rapp, Hans-Dieter Nothdurft, Maria Velasco, Azucena Bardají, Gerardo Rojo-Marcos, Leo G. Visser, Christoph Hatz, Zeno Bisoffi, Tomas Jelinek, Stephan Duparc, Yann Bourhis, Silva Tommasini, Maurizio Iannucelli, Antonella Bacchieri, Giovan Giuseppe Mattera, Emilio Merlo Pich, Ronald H. Behrens

Open source

DOI
10.1186/s12936-021-03750-x
Published
2021-05-08
Container
Malaria Journal
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12936-021-03750-x,
  title = {Longitudinal study based on a safety registry for malaria patients treated with artenimol–piperaquine in six European countries},
  author = {Nicolas Vignier and Olivier Bouchaud and Andrea Angheben and Emmanuel Bottieau and Guido Calleri and Joaquín Salas-Coronas and Charlotte Martin and José Manuel Ramos and Matthieu Mechain and Christophe Rapp and Hans-Dieter Nothdurft and Maria Velasco and Azucena Bardají and Gerardo Rojo-Marcos and Leo G. Visser and Christoph Hatz and Zeno Bisoffi and Tomas Jelinek and Stephan Duparc and Yann Bourhis and Silva Tommasini and Maurizio Iannucelli and Antonella Bacchieri and Giovan Giuseppe Mattera and Emilio Merlo Pich and Ronald H. Behrens},
  year = {2021},
  journal = {Malaria Journal},
  doi = {10.1186/s12936-021-03750-x},
  url = {https://doi.org/10.1186/s12936-021-03750-x}
}

RIS

TY  - JOUR
TI  - Longitudinal study based on a safety registry for malaria patients treated with artenimol–piperaquine in six European countries
AU  - Nicolas Vignier
AU  - Olivier Bouchaud
AU  - Andrea Angheben
AU  - Emmanuel Bottieau
AU  - Guido Calleri
AU  - Joaquín Salas-Coronas
AU  - Charlotte Martin
AU  - José Manuel Ramos
AU  - Matthieu Mechain
AU  - Christophe Rapp
AU  - Hans-Dieter Nothdurft
AU  - Maria Velasco
AU  - Azucena Bardají
AU  - Gerardo Rojo-Marcos
AU  - Leo G. Visser
AU  - Christoph Hatz
AU  - Zeno Bisoffi
AU  - Tomas Jelinek
AU  - Stephan Duparc
AU  - Yann Bourhis
AU  - Silva Tommasini
AU  - Maurizio Iannucelli
AU  - Antonella Bacchieri
AU  - Giovan Giuseppe Mattera
AU  - Emilio Merlo Pich
AU  - Ronald H. Behrens
PY  - 2021
JO  - Malaria Journal
DO  - 10.1186/s12936-021-03750-x
UR  - https://doi.org/10.1186/s12936-021-03750-x
ER  - 

APA

Vignier, N., Bouchaud, O., Angheben, A., Bottieau, E., Calleri, G., Salas-Coronas, J., Martin, C., Ramos, J. M., Mechain, M., Rapp, C., Nothdurft, H., Velasco, M., Bardají, A., Rojo-Marcos, G., Visser, L. G., Hatz, C., Bisoffi, Z., Jelinek, T., Duparc, S., Bourhis, Y., Tommasini, S., Iannucelli, M., Bacchieri, A., Mattera, G. G., Pich, E. M., & Behrens, R. H. (2021). Longitudinal study based on a safety registry for malaria patients treated with artenimol–piperaquine in six European countries. Malaria Journal. https://doi.org/10.1186/s12936-021-03750-x

Source records